Baylor Genetics

About

Baylor Genetics is a leading diagnostic genomics partner that combines the academic and scientific excellence of Baylor College of Medicine with the operational efficiency and commercial reach of H.U. Group Holdings. Established as a joint venture in 2015, the company builds upon a legacy of genetic innovation dating back to 1978. Baylor Genetics specializes in precision medicine, offering a comprehensive portfolio of clinically relevant genetic testing solutions, including Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and targeted panels for various medical specialties such as oncology, pediatrics, and reproductive health. Headquartered in Houston, Texas, within the Texas Medical Center, Baylor Genetics operates a state-of-the-art CLIA-certified and CAP-accredited laboratory. The company is dedicated to ending the diagnostic odyssey for patients by providing rapid, accurate, and actionable genetic insights. Through its integration with electronic health record systems like Epic Aura and the use of advanced technologies such as the DRAGEN Bio-IT Processor, Baylor Genetics empowers healthcare providers to make informed treatment decisions. The organization focuses on scientific discovery, operational excellence, and a patient-centric approach to transform the landscape of genetic diagnostics.